14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.51 $3.02 Friday, 3rd May 2024 GLYC stock ended at $1.83. This is 6.40% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 12.88% from a day low at $1.63 to a day high of $1.84.
90 days $1.51 $3.38
52 weeks $1.11 $3.53

Historical GlycoMimetics prices

Date Open High Low Close Volume
Feb 23, 2023 $1.80 $1.83 $1.71 $1.71 1 746 673
Feb 22, 2023 $1.85 $1.85 $1.70 $1.78 1 367 202
Feb 21, 2023 $1.91 $1.96 $1.82 $1.92 1 707 335
Feb 17, 2023 $1.79 $1.88 $1.62 $1.88 2 279 950
Feb 16, 2023 $1.53 $1.91 $1.50 $1.82 8 397 155
Feb 15, 2023 $2.27 $2.33 $1.45 $1.52 14 632 778
Feb 14, 2023 $3.78 $4.16 $3.67 $4.05 2 178 774
Feb 13, 2023 $3.51 $3.78 $3.38 $3.78 1 436 159
Feb 10, 2023 $3.26 $3.54 $3.22 $3.48 1 348 237
Feb 09, 2023 $3.17 $3.30 $3.00 $3.26 4 860 467
Feb 08, 2023 $3.42 $3.55 $3.14 $3.18 1 310 265
Feb 07, 2023 $3.06 $3.34 $2.93 $3.34 6 951 547
Feb 06, 2023 $3.15 $3.15 $3.02 $3.05 428 668
Feb 03, 2023 $3.03 $3.12 $3.00 $3.09 380 112
Feb 02, 2023 $3.10 $3.12 $2.97 $3.03 733 022
Feb 01, 2023 $2.98 $3.12 $2.92 $3.09 734 653
Jan 31, 2023 $2.87 $3.02 $2.85 $2.91 793 161
Jan 30, 2023 $3.42 $3.42 $2.85 $2.90 1 610 007
Jan 27, 2023 $3.48 $3.60 $3.19 $3.39 1 458 974
Jan 26, 2023 $3.11 $3.35 $3.00 $3.35 4 578 627
Jan 25, 2023 $3.30 $3.48 $3.05 $3.10 2 339 315
Jan 24, 2023 $2.90 $3.22 $2.87 $3.17 921 663
Jan 23, 2023 $2.60 $2.88 $2.60 $2.87 945 923
Jan 20, 2023 $2.57 $2.70 $2.53 $2.56 520 674
Jan 19, 2023 $2.66 $2.74 $2.55 $2.55 509 223
Click to get the best stock tips daily for free!

About GlycoMimetics

GlycoMimetics GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as in phase 3 trial to treat relapsed/refractory AML. In addition, the company is developing G... GLYC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT